Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
併用療法
Document Type and Number:
Japanese Patent JP6869720
Kind Code:
B2
Abstract:
The present disclosure relates to a method for treatment or prevention of diseases have an increased level of insulin-like growth factor I (IGF-I). The method comprises administration of a Somatostatin analogs having agonistic activity in combination with an oligonucleotide targeted to growth hormone receptor (GHR) to a subject in need.

More Like This:
JP6840796Composition for linking DNA binding domain and cleavage domain
JP2002512515INDUSTRIAL APPLICABILITY [Title of Invention] Tumor necrosis factor receptor-related proteins TANGO-63d and TANGO-63e
JP5869885Multi-antigen delivery system using hepatitis E virus-like particles
Inventors:
George Tachas
Application Number:
JP2016518801A
Publication Date:
May 12, 2021
Filing Date:
June 13, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Antisense Therapeutics Limited
International Classes:
A61K31/7088; A61K31/7105; A61K31/711; A61K31/7115; A61K31/712; A61K31/7125; A61K31/713; A61K38/22; A61K45/00; A61P3/00; A61P3/10; A61P5/08; A61P9/10; A61P13/12; A61P27/02; A61P35/00; C12N15/113
Domestic Patent References:
JP2007524373A
JP2004531520A
JP2009539803A
JP2008535882A
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe



 
Previous Patent: 再生利用可能な滅菌状態表示テープ

Next Patent: 不可逆的に阻害されたＣＹＰ４５０ミクロソーム、及び代謝経路の酵素の...